XML 55 R39.htm IDEA: XBRL DOCUMENT v3.25.0.1
Accounting for Share-Based Payments (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Activity in the Company’s Stock Option Plans
Transactions related to stock options for the year ended December 31, 2024 are summarized as follows:
Weighted
Average
Exercise
Price
Options
Outstanding
Weighted
Average
Contractual
Term
(in years)
Intrinsic
Value of
Options
Outstanding at December 31, 2023$13.65 106,197 4.8$— 
Exercised— — 
Canceled, forfeited, or expired14.76 (8,109)
Outstanding at December 31, 2024$13.56 98,088 4.2$— 
Vested and expected to vest at December 31, 2024$— — $— 
Exercisable options$13.56 98,088 4.2$— 
Schedule of Stock Awards Plan Activity
Transactions related to restricted stock awards for the year ended December 31, 2024 are summarized as follows:
SharesWeighted Average
Grant Date Fair Value
Nonvested at December 31, 202368,207 $12.57 
Granted20,061 9.97 
Vested(37,584)15.60 
Forfeited(20,819)9.01 
Nonvested at December 31, 202429,865 $9.49 
Transactions related to inducement stock awards as of December 31, 2024 were as follows:
UnitsWeighted-Average Grant Date Fair Value
Outstanding December 31, 20234,902 $10.21 
Vested(4,902)2.61 
Forfeited/Canceled— $— 
Outstanding December 31, 2024— $— 
Schedule of Nonvested Performance- based Units Activity
The performance stock units are divided into tranches, each one vesting on the date the thirty-day volume-weighted average price of the Company's common stock `meets or exceeds the price target as set forth in the table below:
SharesVolume Weighted Average Price Target
Tranche I11,590 $13.00 
Tranche II11,589 16.00 
Tranche III11,588 19.00 
Tranche IV50,000 25.00 
Tranche V40,000 27.50 
Tranche VI30,000 30.00 
Tranche VII30,000 $35.00 
Transactions related to performance stock units for the year ended December 31, 2024 were as follows:
UnitsWeighted-Average Grant Date Fair Value
Outstanding at December 31, 2023324,635 $2.16 
Granted20,061 2.61 
Forfeited(159,929)0.61 
Outstanding at December 31, 2024184,767 $3.49